 |
|
Human Chorionic Gonadotropin (HCG) Treatment of Obesity
Kaup R. Shetty, MD;
Ronald K. Kalkhoff, MD
Arch Intern Med. 1977;137(2):151-155.
Abstract
After a nine-day control period, six hospitalized obese women were placed on 500 calorie diets and were given 125 IU of human chorionic gonadotropin (HCG) intramuscularly daily for 30 days. Another five obese women received injections of diluent only and consumed identical diets for the same period. Mean weight loss in the HCG-treated group was nearly identical to that achieved by women given the placebo. Reduction of triceps skinfold thickness or circumferential body measurements of the chest, waist, hips, and thighs were not different. Patterns of change of a variety of plasma and urine substrates, electrolytes, and hormones were similar in the two groups and consistent with semistarvation and weight loss. These results indicate that HCG has no effects on chemical and hormonal parameters measured and offers no advantage over calorie restriction in promoting weight loss.
(Arch Intern Med 137:151-155, 1977)
Author Affiliations
From the Endocrine-Metabolic Section, Department of Medicine, Milwaukee County Medical Complex, and Wood Veterans Administration Center, the Medical College of Wisconsin, and Deaconess Hospital, Milwaukee.
Footnotes
Received for publication March 2, 1976; accepted June 10.
Reprint requests to Endocrine-Metabolic Section, Veterans Administration Center, Wood, WI 53193 (Dr Shetty).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Current and Potential Drugs for Treatment of Obesity
Bray and Greenway
Endocr Rev 1999;20:805-875.
ABSTRACT
| FULL TEXT
|
